Outcome of Treatment of MDR-TB Patients with Standardized Regimens; Iran's Experience 2002-2006

被引：1
|
作者：
Masjedi, M. R. [1 ]
Tabarsi, P. [1 ]
Chitsaz, E. [1 ]
Velayati, A. [1 ]
机构：
[1] NRITLD, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.679
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E250 / E251
页数：2
相关论文
共 50 条
  • [21] The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
    Uzma Khan
    Helena Huerga
    Aamir J. Khan
    Carole D. Mitnick
    Catherine Hewison
    Francis Varaine
    Mathieu Bastard
    Michael Rich
    Molly F. Franke
    Sidney Atwood
    Palwasha Y. Khan
    Kwonjune J. Seung
    BMC Infectious Diseases, 19
  • [22] MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin
    Ade, S.
    Trebucq, A.
    Harries, A. D.
    Affolabi, D.
    Ade, G.
    Agodokpessi, G.
    Wachinou, P.
    Anagonou, S.
    Gninafon, M.
    PUBLIC HEALTH ACTION, 2013, 3 (02): : 160 - 165
  • [23] Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents
    Sagwa, E. L.
    Ruswa, N.
    Mavhunga, F.
    Rennie, T.
    Mengistu, A.
    Mekonen, T. T.
    Leufkens, H. G. M.
    Mantel-Teeuwisse, A. K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (12) : 1245 - 1250
  • [24] The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
    Augusto, Sablan, Jr.
    Gonong, Joven
    Raymond, Lawrence
    Lofranco, Vivian
    Balanag, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] THE INCIDENCE OF MULTI DRUG RESISTANT TUBERCULOSIS AMONG PATIENTS RECEIVING STANDARDIZED TREATMENT REGIMEN FOR SUSPECTED MDR-TB
    Sablan, Augusto J. R.
    Gonong, Joven R.
    Balanag, Vincent B.
    Raymond, Lawrence S.
    RESPIROLOGY, 2013, 18 : 10 - 10
  • [26] Long Term Treatment Outcome in Multi Drug Resistant Tuberculosis (MDR-TB)
    Prasad, R.
    Verma, S. K.
    Verma, S. K.
    Jain, A.
    Ahuja, R. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [27] Specific gyrA gene mutations predict poor treatment outcome in MDR-TB
    Rigouts, L.
    Coeck, N.
    Gumusboga, M.
    de Rijk, W. B.
    Aung, K. J. M.
    Hossain, M. A.
    Fissette, K.
    Rieder, H. L.
    Meehan, C. J.
    de Jong, B. C.
    Van Deun, A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (02) : 314 - 323
  • [28] Long term treatment outcome in multi drug resistant tuberculosts(MDR-TB)
    Prasad, R
    CHEST, 2004, 126 (04) : 836S - 836S
  • [29] Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome
    Huang, Yi-Wen
    Tsai, Hsin-Chieh
    Chen, Chia-Ming
    Yu, Ya-Yen
    Shen, Gwan-Han
    Yang, Wen-Ta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [30] Early experience with the implementation of the WHO shorter MDR-TB treatment regimen in Singapore
    She, Hoi Wah
    Wang, Yee Tang
    Gan, Suay Hong
    Chua, Angeline Poh Gek
    Chee, Cynthia Bee Eng
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345